Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unpreserved dexamethasone phosphate 0.1% eye drops vs placebo in severe Sjögren-related keratoconjunctivitis sicca
2006-003391-35Phase 4Active
- Sponsor
- Laboratoires Théa
- Start
- Jul 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in dry eye syndrome (DED) and Sjögren's syndrome comparing T1910 dexamethasone sodium phosphate eye drops with Placebo eye drops (2 arms). Primary endpoint: Primary efficacy criteria. Started Jul 2006; status: active.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on 2006-003391-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003391-35.